![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Micro Labs Limited Bengaluru In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Irbesartan, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2011-176 - Rev 03
This Chemical Type CEP, issued on February 03, 2020, remains in force until June 10, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2465 associated with this CEP further emphasizes